| Clinical data | |
|---|---|
| Other names | PeMA; 2,3,4,5,6-Pentamethoxyamphetamine; 2,3,4,5,6-PeMA; 2,6-Dimethoxy-TMA; 3,6-Dimethoxy-TMA-2 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C14H23NO5 |
| Molar mass | 285.340 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Pentamethoxyamphetamine (PeMA), also known as 2,3,4,5,6-pentamethoxyamphetamine (2,3,4,5,6-PeMA), 2,6-dimethoxy-TMA, or 3,6-dimethoxy-TMA-2, is a chemical compound of the phenethylamine and amphetamine families related to the psychedelic drug mescaline (3,4,5-trimethoxyphenethylamine).12 It is the α-methyl or amphetamine derivative of pentamethoxyphenethylamine (PeMPEA).12 The compound does not seem to have been tested in animals or humans.12 However, the related drug PeMPEA is known to be behaviorally active in animal studies.13 PeMA was first described in the scientific literature by Alexander Shulgin by 1969.2 It is a controlled substance in Canada under phenethylamine blanket-ban language.4
See also
See also
References
References
- Shulgin A, Manning T, Daley PF (2011). "#108. PeMPEA". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 263–264. ISBN 978-0-9630096-3-0. OCLC 709667010.
- Shulgin AT, Sargent T, Naranjo C (1969). "Structure–Activity Relationships of One-Ring Psychotomimetics". Nature. 221 (5180): 537–541. doi:10.1038/221537a0. ISSN 0028-0836. PMID 5789297.
- Brimblecombe RW, Pinder RM (1975). "Phenylalkylamines and Their Derivatives". Hallucinogenic Agents. Bristol: Wright-Scientechnica. pp. 55–97.
Table 3.2.—Relative Hallucinogenic Potencies of Some Phenylethylamines [...]
- "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.